Validation for safety and efficacy of axillary reverse mapping using ICG in terms of prevention for lymphedema of upper limb in breast cancer
Phase 1
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000031880
- Lead Sponsor
- agasaki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
patients with sensitivity to ICG or other drugs pregnant patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method percentage of lymph edema in upper limb adverse events
- Secondary Outcome Measures
Name Time Method percentage of detection of lymph ducts detail of lymph ducts local recurrence rate of axillary lymph nodes